CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Sorbic acid 50mg  | ≥99%

CSNpharm

Sorbic Acid inhibits growth of fungi, yeast, mold and some bacteria and is nearly nontoxic to humans. It’s a natural preservative that comes from the rowan berries, Sorbus aucuparia (family Rosaceae) and widely used in foods, drugs, and cosmetic products as preservatives.

More Information Supplier Page

SP-146 10mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-146 100mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-146 1mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-146 25mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-146 50mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-146 5mg  | ≥99%

CSNpharm

SP-146 is a highly selective and non-ATP-competitive Aurora A/B inhibitor with IC50 values of 0.316nM 18.975 nM for Aurora A and Aurora B, respectively.

More Information Supplier Page

SP-600125 50mg  | ≥98%

CSNpharm

SP-600125 is a competitive and reversible JNK inhibitor with IC50 values of 40 nM, 40 nM and 90 nM for JNK1, 2 and 3.

More Information Supplier Page

SP-600125 10mg  | ≥98%

CSNpharm

SP-600125 is a competitive and reversible JNK inhibitor with IC50 values of 40 nM, 40 nM and 90 nM for JNK1, 2 and 3.

More Information Supplier Page

SP-600125 250mg  | ≥98%

CSNpharm

SP-600125 is a competitive and reversible JNK inhibitor with IC50 values of 40 nM, 40 nM and 90 nM for JNK1, 2 and 3.

More Information Supplier Page

SP-600125 100mg  | ≥98%

CSNpharm

SP-600125 is a competitive and reversible JNK inhibitor with IC50 values of 40 nM, 40 nM and 90 nM for JNK1, 2 and 3.

More Information Supplier Page

Sparteine 100mg  | ≥99%

CSNpharm

Sparteine competitively blocks nicotinic ACh receptor in the neurons. It also inhibited human CYP2D6 expressed in Escherichia coli JM109.

More Information Supplier Page

Spectinomycin 2HCl 5H2O 5mg  | ≥95%

CSNpharm

Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.

More Information Supplier Page

Spectinomycin 2HCl 5H2O 10mg  | ≥95%

CSNpharm

Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.

More Information Supplier Page

Spectinomycin 2HCl 5H2O 25mg  | ≥95%

CSNpharm

Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.

More Information Supplier Page

Spectinomycin 2HCl 5H2O 50mg  | ≥95%

CSNpharm

Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.

More Information Supplier Page

Spermine 25mg  | ≥90%

CSNpharm

Spermine is a polyamine derived from spermidine by spermine synthase, functions as a free radical scavenger and forms a variety of adducts that prevent oxidative damage to DNA. Spermine is also implicated in the regulation of gene expression, the stabilization of chromatin and the prevention of endonuclease-mediated DNA fragmentation. Also used for nutritional supplementation and […]

More Information Supplier Page

Spermine 100mg  | ≥90%

CSNpharm

Spermine is a polyamine derived from spermidine by spermine synthase, functions as a free radical scavenger and forms a variety of adducts that prevent oxidative damage to DNA. Spermine is also implicated in the regulation of gene expression, the stabilization of chromatin and the prevention of endonuclease-mediated DNA fragmentation. Also used for nutritional supplementation and […]

More Information Supplier Page

Sphingosine-1-phosphate 5mg  | ≥98%

CSNpharm

Sphingosine-1-phosphate is the product of phosphorylation of sphingosine by sphingosine kinase and ligand for EDG-1 and EDG-3 and activator of GPR3, GPR6, and GPR12.

More Information Supplier Page

Sphingosine-1-phosphate 1mg  | ≥98%

CSNpharm

Sphingosine-1-phosphate is the product of phosphorylation of sphingosine by sphingosine kinase and ligand for EDG-1 and EDG-3 and activator of GPR3, GPR6, and GPR12.

More Information Supplier Page

SPHINX31 25mg  | ≥99%

CSNpharm

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

More Information Supplier Page

SPHINX31 10mg  | ≥99%

CSNpharm

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

More Information Supplier Page

SPHINX31 5mg  | ≥99%

CSNpharm

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

More Information Supplier Page

SPHINX31 50mg  | ≥99%

CSNpharm

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

More Information Supplier Page

Sphondin 10mg  | ≥99%

CSNpharm

Sphondin, a natural product isolated and purified from the fruits of Heracleum sibiricum L., possesses an inhibitory effect on IL-1beta-induced increase in the level of COX-2 protein and PGE(2) release in A549 cells.

More Information Supplier Page

Sphondin 25mg  | ≥99%

CSNpharm

Sphondin, a natural product isolated and purified from the fruits of Heracleum sibiricum L., possesses an inhibitory effect on IL-1beta-induced increase in the level of COX-2 protein and PGE(2) release in A549 cells.

More Information Supplier Page

Sphondin 5mg  | ≥99%

CSNpharm

Sphondin, a natural product isolated and purified from the fruits of Heracleum sibiricum L., possesses an inhibitory effect on IL-1beta-induced increase in the level of COX-2 protein and PGE(2) release in A549 cells.

More Information Supplier Page

Spinosin 5mg  | ≥98%

CSNpharm

Spinosin is a flavone C-glycoside which can be isolated from the seeds of Zizyphus jujuba with anxiolytic-like effects. Spinosin could ameliorate memory impairment induced through AβO.

More Information Supplier Page

Spiromustine 10mg  | ≥98%

CSNpharm

NCI172112 is a new lipophilic alkylating agent with good capable of penetrating the CNS and it also enhances alkylating activity against other than brain tumors.

More Information Supplier Page

Spiromustine 5mg  | ≥98%

CSNpharm

NCI172112 is a new lipophilic alkylating agent with good capable of penetrating the CNS and it also enhances alkylating activity against other than brain tumors.

More Information Supplier Page

Spiromustine 25mg  | ≥98%

CSNpharm

NCI172112 is a new lipophilic alkylating agent with good capable of penetrating the CNS and it also enhances alkylating activity against other than brain tumors.

More Information Supplier Page

Spiromustine 1mg  | ≥98%

CSNpharm

NCI172112 is a new lipophilic alkylating agent with good capable of penetrating the CNS and it also enhances alkylating activity against other than brain tumors.

More Information Supplier Page